1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"DoW Breast Cancer, Era of Hope Scholar Award" is currently closed and not accepting applications.
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the Intent of the FY26 BCRP Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the award’s central features include the Principal Investigator’s (PI’s) demonstrated ability to go beyond conventional thinking in their field and the innovative and meaningful contributions that they can make toward ending breast cancer. The Era of Hope Scholar Award requires exceptionally talented scientists that are among “the best and the brightest” in their field(s), with demonstrated experience forming effective partnerships and collaborations and strong potential for future leadership in breast cancer research. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:· The PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award.· The research team must include two or more breast cancer consumer advocates.
Funding Opportunity Number: HT942526BCRPEOHS. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $4.9M total program funding.
Get alerted about grants like this
Get emailed when new opportunities from “Defense Health Agency Contracting Activity - DHACA” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility. Confirm the full requirements in the official notice before applying.
The current listing shows $4.9M total program funding. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 8, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Yes — DoW Breast Cancer, Era of Hope Scholar Award is offered by Defense Health Agency Contracting Activity - DHACA and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Between FY2021 and FY2025, the Defense Health Agency made 8,861 awards totaling about $7.0 billion to 684 recipients, with a median award of $772,480. The Henry M. Jackson Foundation for the Advancement of Military Medicine ($548.9 million) and The Johns Hopkins University ($155.5 million) were among the top recipients, and 65 percent of recipients won more than one separate award.
| Organization | Total awarded |
|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, INC.(MD) | $548.9M |
| The Univeristy of Texas M.d. Anderson Cancer Center(TX) | $168.0M |
| The Johns Hopkins University(MD) | $155.5M |
| Regents of the University of California, San Francisco, the(CA) | $147.2M |
| University of Pittsburgh - of the Commonwealth System of Higher Education(PA) | $124.0M |
| Duke University(NC) | $123.5M |
| The General Hospital Corporation(MA) | $117.0M |
| Ohio State University, the(OH) | $100.6M |
Linked organizations have Granted profiles. Top recipients of Defense Health Agency assistance awards, FY2021–FY2025, ranked by total obligations (CFDA 12.42.x). Source: USAspending. Last verified July 2026.
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Concept Award supports highly innovative, untested, potentially groundbreaking concepts, theories, paradigms and/or basic kidney cancer research. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in kidney cancer. Applications must describe how the new concept will be innovative and present a novel course of investigation in the field of kidney cancer. Distinctive Features: • Preliminary data are not allowed. • This is a blinded funding mechanism. Applications to this funding opportunity will undergo a double-blinded peer review. Applications must not include any materials that may identify the Principal Investigator (PI), a collaborator, or the organization of the PI or collaborator. • Due to the blinded nature of the review process, identifying or making references to the PI, collaborator(s), or their organization(s) in the proposal (Project Narrative, List of Abbreviations, Acronyms, Symbols, Statement of Work, Impact Statement and Innovation Statement) is prohibited and will result in administrative rejection of the application. Funding Opportunity Number: HT942526KCRPCA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $840K total program funding.
DoW Peer Reviewed Medical, Research Advancement Award is sponsored by Defense Health Agency Contracting Activity - DHACA. Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related…
The Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read articleElevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read articleThe Elevance Health Foundation's Maternal/Infant Health RFP funds nonprofits — up to ~$1M over 1-3 years — working to close disparities across the full pregnancy journey. Applications close July 31, 2026, with a national track and a local track in ten named states. Here's how the funder thinks, what 'measurable outcomes' really means here, and how to build a proposal that clears the bar.
Read article